(Q62062052)

English

BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma

clinical trial

Statements

a Single-center, One Arm, Open Clinical Study of BCMA Nanobody CAR-T Cell in Refractory/Relapsed Myeloma (English)
0 references
11 April 2018
0 references
10 April 2019
0 references
15
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit